These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 29929464)
21. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B; Khunt D; Misra M; Padh H Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654 [TBL] [Abstract][Full Text] [Related]
22. Hydroxyapatite nanoparticles: preparation, characterization, and evaluation of their potential use in bone targeting: an animal study. Maia AL; Cavalcante CH; Souza MG; Ferreira Cde A; Rubello D; Chondrogiannis S; Cardoso VN; Ramaldes GA; Barros AL; Soares DC Nucl Med Commun; 2016 Jul; 37(7):775-82. PubMed ID: 27076207 [TBL] [Abstract][Full Text] [Related]
23. The nasal delivery of nanoencapsulated statins - an approach for brain delivery. Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459 [TBL] [Abstract][Full Text] [Related]
24. Application of Box-Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles. Maleki Dizaj S; Lotfipour F; Barzegar-Jalali M; Zarrintan MH; Adibkia K Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1475-81. PubMed ID: 25950955 [TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation. Rajpoot K; Jain SK Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671 [TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
28. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization. Sah AK; Suresh PK Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117 [TBL] [Abstract][Full Text] [Related]
29. Preparation of Calcium Phosphate/pDNA Nanoparticles for Exogenous Gene Delivery by Co-Precipitation Method: Optimization of Formulation Variables Using Box-Behnken Design. Li W; Zhang X; Jing S; Xin X; Chen K; Chen D; Hu H J Pharm Sci; 2017 Aug; 106(8):2053-2059. PubMed ID: 28483423 [TBL] [Abstract][Full Text] [Related]
30. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir. Ravi PR; Vats R; Dalal V; Gadekar N; N A Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260 [TBL] [Abstract][Full Text] [Related]
31. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery. Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317 [TBL] [Abstract][Full Text] [Related]
32. Optimization and evaluation of bioactive drug-loaded polymeric nanoparticles for drug delivery. Rani R; Dilbaghi N; Dhingra D; Kumar S Int J Biol Macromol; 2015; 78():173-9. PubMed ID: 25881957 [TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112 [TBL] [Abstract][Full Text] [Related]
34. Tetraethylorthosilicate (TEOS) applied in the surface modification of hydroxyapatite to develop polydimethylsiloxane/hydroxyapatite composites. Bareiro O; Santos LA Colloids Surf B Biointerfaces; 2014 Mar; 115():400-5. PubMed ID: 24503294 [TBL] [Abstract][Full Text] [Related]
35. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability. Pantub K; Wongtrakul P; Janwitayanuchit W J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206 [TBL] [Abstract][Full Text] [Related]
36. Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles. Gupta B; Poudel BK; Pathak S; Tak JW; Lee HH; Jeong JH; Choi HG; Yong CS; Kim JO AAPS PharmSciTech; 2016 Jun; 17(3):652-62. PubMed ID: 26304931 [TBL] [Abstract][Full Text] [Related]
37. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Saini D; Fazil M; Ali MM; Baboota S; Ali J Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039 [TBL] [Abstract][Full Text] [Related]